MGRX
Mangoceuticals, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.41
+5.30%Margins
Gross margin
54.4%
EBITDA margin
-4350.3%
EBIT margin
-4185.1%
Net margin
-4791.5%
FCF margin
-1234.3%
-120.6%
Return on equity
-106.6%
Return on assets
-102.7%
Return on invested capital
0.02x
Asset turnover
-$3.9M
Cash from operations
$0.01
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026